Action MedTech Acquisition - MTAC

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

11,34

Prix Achat

11,30

Prix Vente

11,94

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Cap du marché

22,147M

Clôture Veille

11,34

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

Actions en circulation

1 953 000

Rendement du Dividende

Ratio Cours sur Bénéfices

-0,35

Bénéfice par action (BPA)

-32,4

Chiffre d'affairess

18,51M

Bénéfice net

-63,28M

MedTech Acquisition Corp is a blank check company. MedTech Acquisition Corp is a blank check company.

Secteur

Surgical,med Instr,apparatus

Industrie

Blank Checks

Siège social

Wilmington, Delaware, USA

Fondé

2023

MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders

MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company”) today announced that it convened and then adjourned, without...

TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting

New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment and decreased circulating tumor...

TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases

TriSalus Life Sciences® Inc., (“TriSalus” or the “Company”), an oncology company in the process of going public through a business combination...

TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business

TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”), an oncology company in the process of going public through a business combination...

MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders

The Company recommends all of its stockholders to vote FOR the Extension Amendment at the upcoming Special Meeting. New York, NY, Dec. 07, 2022...

MedTech Acquisition Corporation and Memic Innovative Surgery Ltd. Mutually Agree to Terminate Business Combination

TEL AVIV, Israel and FORT LAUDERDALE, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech”), a...

Memic Announces Adoption of Hominis® Surgical System at Three Leading U.S. Hospitals in Q4 2021

Memic Announces Adoption of Hominis® Surgical System at Three Leading U.S. Hospitals in Q4 2021 HCA Florida Healthcare's Kendall Regional Medical...

Memic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition Corporation

Memic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition...

Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal

Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal PR Newswire OR YEHUDA, Israel, Aug. 19, 2021 OR YEHUDA, Israel, Aug...

Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination

Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination - Memic's Hominis® platform is the first...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

MTAC - Frequently Asked Questions (FAQ)

What is the current MedTech Acquisition share price?

The current share price of MedTech Acquisition is US$ 11,34

How many MedTech Acquisition shares are in issue?

MedTech Acquisition has 1 953 000 shares in issue

What is the market cap of MedTech Acquisition?

The market capitalisation of MedTech Acquisition is USD 22,15M

What is the 1 year trading range for MedTech Acquisition share price?

MedTech Acquisition has traded in the range of US$ 0,00 to US$ 0,00 during the past year

What is the PE ratio of MedTech Acquisition?

The price to earnings ratio of MedTech Acquisition is -0,35

What is the cash to sales ratio of MedTech Acquisition?

The cash to sales ratio of MedTech Acquisition is 1,2

What is the reporting currency for MedTech Acquisition?

MedTech Acquisition reports financial results in USD

What is the latest annual turnover for MedTech Acquisition?

The latest annual turnover of MedTech Acquisition is USD 18,51M

What is the latest annual profit for MedTech Acquisition?

The latest annual profit of MedTech Acquisition is USD -63,28M

What is the registered address of MedTech Acquisition?

The registered address for MedTech Acquisition is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

Which industry sector does MedTech Acquisition operate in?

MedTech Acquisition operates in the BLANK CHECKS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
MASS908 Devices Inc	US$ 3,88 (95,96%)	124,48M
FRGTFreight Technologies Inc	US$ 1,5606 (51,51%)	77,46M
HOTHHoth Therapeutics Inc	US$ 1,23 (41,38%)	11,43M
JZXNJiuzi Holdings Inc	US$ 4,29 (41,12%)	98,71k
ATLNAtlantic International Corporation	US$ 4,61 (40,12%)	136,23k
AGHAureus Greenway Holdings Inc	US$ 0,7621 (-64,88%)	4,46M
NKGNNKGen Biotech Inc	US$ 0,1944 (-62,31%)	8,44M
TNYATenaya Therapeutics Inc	US$ 0,4206 (-55,58%)	25,91M
PSTVPlus Therapeutics Inc	US$ 0,302249 (-54,20%)	4,78M
PCLAPicoCELA Inc	US$ 1,56 (-50,16%)	1,13M
NVDANVIDIA Corporation	US$ 115,99 (1,69%)	388,45M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 11,52 (-9,08%)	191,17M
INTCIntel Corporation	US$ 21,33 (-6,20%)	149,4M
BTOGBit Origin Ltd	US$ 0,35 (9,61%)	134,93M
TQQQProShares UltraPro QQQ	US$ 69,31 (-1,10%)	129,77M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

MedTech Acquisition Corporation (MTAC)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de MedTech Acquisition Corporation

MTAC Dernières nouvelles

MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders

TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting

TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases

TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business

MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders

MedTech Acquisition Corporation and Memic Innovative Surgery Ltd. Mutually Agree to Terminate Business Combination

Memic Announces Adoption of Hominis® Surgical System at Three Leading U.S. Hospitals in Q4 2021

Memic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition Corporation

Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal

Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination

MTAC - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

MedTech Acquisition Corporation (MTAC) Cours

MedTech Acquisition Corporation (MTAC)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de MedTech Acquisition Corporation

MTAC Dernières nouvelles

MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders

TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting

TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases

TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business

MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders

MedTech Acquisition Corporation and Memic Innovative Surgery Ltd. Mutually Agree to Terminate Business Combination

Memic Announces Adoption of Hominis® Surgical System at Three Leading U.S. Hospitals in Q4 2021

Memic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition Corporation

Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal

Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination

MTAC - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS